• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Improvement of Dissolution Rate and Stability in a Pirenoxine Ophthalmic Suspension by the Bead Mill Methods].

作者信息

Ueno Akina, Yamaoka Sakie, Ito Yoshimasa, Kotake Takeshi, Nakazawa Yosuke, Nagai Noriaki

机构信息

Faculty of Pharmacy, Kindai University.

Faculty of Pharmacy, Keio University.

出版信息

Yakugaku Zasshi. 2017;137(5):635-641. doi: 10.1248/yakushi.16-00267.

DOI:10.1248/yakushi.16-00267
PMID:28458295
Abstract

Foreign matter sensation and blurred vision following instillation of ophthalmic suspension are often observed, and remaining of solid particle on cornea is related these side effects. In addition, low dispersion stability in the ophthalmic suspension affects the therapeutic effect. In this study, we have attempted to enhance the dissolution rate and stability of commercially available pirenoxine ophthalmic suspension (CA-pirenoxine eye drops), anti-cataract eye drops, by changes in particle size. Methylcellulose, zirconia beads (0.1 mm) and Micro Smash were used to mill the pirenoxine (bead mill method), and the distribution of particle size was changed to approximately 60-900 nm (nanodispersions) from 70 nm-3 μm (CA-pirenoxine eye drops). The dissolution rate of pirenoxine increased by the bead mill, and the dissolution rate constant in pirenoxine nanodispersions was 2.1-fold than that in CA-pirenoxine eye drops. Moreover, the dispersion stability in nanodispersions also significant higher in comparison with the CA-pirenoxine eye drops. The dispersion ratio in CA-pirenoxine eye drops and pirenoxine nanodispersions at 2 d after suspension was 48%, 99%, respectively. In conclusion, we showed that the dissolution rate and dispersion stability of CA-pirenoxine eye drops were enhanced by the bead mill method. These findings provide significant information that can be used in the design of ophthalmic suspension.

摘要

相似文献

1
[Improvement of Dissolution Rate and Stability in a Pirenoxine Ophthalmic Suspension by the Bead Mill Methods].
Yakugaku Zasshi. 2017;137(5):635-641. doi: 10.1248/yakushi.16-00267.
2
A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.一种纳米颗粒制剂可降低吲哚美辛滴眼液的角膜毒性并增强其角膜通透性。
Toxicology. 2014 May 7;319:53-62. doi: 10.1016/j.tox.2014.02.012. Epub 2014 Mar 2.
3
Size effect of rebamipide ophthalmic nanodispersions on its therapeutic efficacy for corneal wound healing.瑞巴派特眼用纳米分散体对角膜伤口愈合治疗效果的尺寸效应
Exp Eye Res. 2016 Oct;151:47-53. doi: 10.1016/j.exer.2016.07.003. Epub 2016 Jul 14.
4
A Nanoparticle-Based Ophthalmic Formulation of Dexamethasone Enhances Corneal Permeability of the Drug and Prolongs Its Corneal Residence Time.一种基于纳米颗粒的地塞米松眼用制剂可增强药物的角膜通透性并延长其在角膜的停留时间。
Biol Pharm Bull. 2017;40(7):1055-1062. doi: 10.1248/bpb.b17-00137.
5
[Ocular Drug Delivery System-based on Solid Nanoparticles].基于固体纳米颗粒的眼用药物递送系统
Yakugaku Zasshi. 2021;141(1):47-53. doi: 10.1248/yakushi.20-00177-3.
6
Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders - Part I.厄贝沙坦纳米混悬剂和颗粒状或珠层状干粉末的配方和性能 - 第一部分。
Int J Pharm. 2019 Sep 10;568:118189. doi: 10.1016/j.ijpharm.2019.03.007. Epub 2019 Mar 6.
7
Suppression of presbyopia progression with pirenoxine eye drops: experiments on rats and non-blinded, randomized clinical trial of efficacy.吡诺克辛滴眼液抑制老视进展的实验研究及非盲、随机临床疗效观察。
Sci Rep. 2017 Jul 28;7(1):6819. doi: 10.1038/s41598-017-07208-6.
8
A nanoparticle formulation of disulfiram prolongs corneal residence time of the drug and reduces intraocular pressure.双硫仑的纳米颗粒制剂可延长药物在角膜的停留时间并降低眼压。
Exp Eye Res. 2015 Mar;132:115-23. doi: 10.1016/j.exer.2015.01.022. Epub 2015 Jan 26.
9
[Design of Novel Ophthalmic Formulation Containing Drug Nanoparticles and Its Usefulness as Anti-glaucoma Drugs].[含药物纳米颗粒的新型眼科制剂的设计及其作为抗青光眼药物的效用]
Yakugaku Zasshi. 2016;136(10):1385-1390. doi: 10.1248/yakushi.16-00089.
10
Development of stabilized itraconazole nanodispersions by using high-gravity technique.利用高重力技术制备稳定的伊曲康唑纳米分散体。
Drug Dev Ind Pharm. 2012 Dec;38(12):1512-20. doi: 10.3109/03639045.2012.654794. Epub 2012 Mar 22.